AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Turpaz Industries Ltd.

Investor Presentation May 18, 2022

7098_rns_2022-05-18_4cbaa9b0-f6cf-4759-905c-ddfb4d058d43.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

INVESTOR PRESENTATION

1

DISCLAIMER This presentation was prepared by Turpaz Industries Ltd. (the "Company") for the sole purpose of conveying information regarding the Company and its subsidiaries (together with the Company "Turpaz Group"). This presentation does not constitute, or form part of, an offer to sell, or a solicitation of an offer to purchase any securities of the Company and is intended to provide information only. This presentation is not intended to replace the need to review the Company's full reports to the Securities Authority and the Tel Aviv Stock Exchange Ltd. (hereinafter: "Company Reports") prior to making a decision regarding investment in the Company's securities.

In addition, this presentation cannot replace investment consulting by a lawfully licensed investment consultant.

This presentation includes statements data, forecasts, goals and Company plans that are "forward-looking statements", as defined in the Securities Law - 1968, whose occurrence is not certain, and which are not solely in the Company's control. These forward-looking statements are included, inter alia, in discussions of strategy, objectives, goals, plans, events, future intentions or other information relating to future events or issues whose occurrence is not certain.

By their nature, forward-looking statements involve risk and uncertainty. Whether the forward-looking information occurs or not is affected, inter alia, by risk factors characteristic to the Company's operations and developments in the general environment and external factors which impact the Turpaz Group and its area of activities.

Subject to the requirements of applicable law, the Company does not intend to update any industry information or forward-looking statements appearing in this presentation and is not required to publish any additional presentations for its shareholders in future.

HIGHLIGHTS Q1 (US \$)

Sales \$ 27.4M + 42.5% Sales growth + 9.5% Organic growth Gross profit \$ 10.7 Strong cash flow from operation \$ 5.4M

+42.9% Solid balance sheet, funding availability and strong cash flow from operations facilitate growth and acquisitions strategy in Q2)

\$ 6.3M +35.4% Accomplished 6 acquisitions from IPO (May 21) – 3 in 2022 (1 reflected in Q1 and 2

Adjusted EBITDA

Turpaz implemented a strategy of rapid double-digit growth, combining organic growth with synergistic and strategic acquisition

4 (*) Adj EBITDA - earnings before interest, taxes, depreciation, and amortization neutralization of one-time expenses of acquisitions (**) based on the company's internal reporting

TURPAZ – CONSOLIDATED

In K US \$ / % Q1 2021 Q1 2022
Sales 19,237 27,405
Gross profit 7,490
38.9%
10,704
39.1%
Operating profit 3,868
20.1%
4,557
16.6% (*)
Adj. EBITDA 4,667 6,318

(*) Decrease in operating margin due to:

(1) \$350K - amortization of intangible assets

(2) \$150K - option share-based payment

(3) \$400K - recruitment of management teams and strengthening of the company's managerial infrastructure

FRAGRANCES
In K US \$ / % Q1 2021 Q1 2022
Sales 4,332 5,992
Operating profit 1,533
35.5%
1,793
30.0%
Organic growth +13.6%
Acquisitions Lori
Highlights Strong
organic
growth
LORI
profitability
is
lower
than
segment
profitably
6
TASTE
In K US \$ / % Q1 2021 Q1 2022
Sales 6,146 13,198
Operating profit 274
4.5%
1,743
13.2%
Organic growth +17.9%
Acquisitions 2021-
Pilpel
& Galilee Herb, FIT
2022(*) -
Balirom and Pentaor
Highlights Acquisitions
and
Profitably
product
lines
&
organic
growth
brought
strong
growth.
SDA's
increased
due
to
improvement
of
operational
efficiency.

(*) will contribute to the company's financial results from Q2 2022

P-
INTERMEDIATES
P
In K US \$ / % Q1 2021 Q1 2022
Sales 5,287 3,285
Operating profit 1,612
30.5%
923
28.1%
Organic growth -35.4%
Highlights Revenues
decreased
mainly
due
to
timing
difference
of
receiving
orders
from
North
American
customers.
Profitability
mainly
affected
from
Euro
USD
impacts.

S -
INTERMEDIATES
S
In K US \$ / % Q1 2021 Q1 2022
Sales 3,482 4,930
Operating profit 1,010
29.0%
1,275
25.9%
Organic growth 44.0%
Highlights Revenues
increased
in
receiving
orders
Profitability
mainly
mainly
due
to
timing
different
from
Asian
customers.
affected
from
Euro
USD
impacts.

P&L – SIGNIFICANT

K US
\$
2021 Q1 2021 Q1 2022
Revenues 85,334 19,237 27,405
Gross Profit 34,728 7,490 10,704
GP% 40.7% 38.9% 39.1%
R&D Expenses 1,949 387 785
Sales & Marketing expenses 6,274 1,200 2,343
Management & General expenses 10,257 1,982 3,027
Other Expense (Income) 208 53 )8(
Operating Profit 16,040 3,868 4,557
OP% 18.8% 20.1% 16.6%
Net Profit 12,812 3,122 3,960
EBIDTA 20,021 4,667 6,213
Adj. EBIDTA (*) 20,475 4,667 6,318
% Adj. EBIDTA 24.0% 24.3% 23.1%
Cash flow from operation 12,283 1,875 5,368

* Q1 2022 non-recurring expenses included legal and other expenses relating to acquisitions during the reporting period, amounting to \$105K.

BALANCE SHEET

K
US \$
31/12/2021 31/3/2021 31/3/2022
Assets
Current Assets 106,082 36,541 99,208
Non-Current Assets 66,587 34,350 79,143
Total Assets 172,669 70,891 178,351
Liabilities & Equity
Current Liabilities 37,032 28,246 38,176
Non-Current Liabilities 42,521 27,205 49,091
Equity 93,116 15,440 91,084
Total Liabilities and Equity 172,669 70,891 178,351

Solid balance sheet, funding availability and strong cash flow from operations facilitate growth and acquisitions strategy

Ratio
Working capital to sales 24.2% 27.4% 22.6%
Net Cash (Net Debts)(*) 20,911 (18,944) 6,579
Equity to total balance sheet 54% 22% 51%

(*) Debts = Short and long-term loans from banks and other and liabilities relating to acquisitions

PROVEN TRACK RECORD OF ACQUISITIONS

Multinational Company

THANK YOU

Talk to a Data Expert

Have a question? We'll get back to you promptly.